Google Scholar | Citations: 16429| h-index: 32 | i10-index: 482
Heart transplantation in the treatment of chagasic myocardiopathy
PDF (Portuguese (Brazil))

Supplementary Files

Certificado de publicação (Portuguese (Brazil))

Keywords

Heart transplatation
Chagas disease
Treatment

How to Cite

Heart transplantation in the treatment of chagasic myocardiopathy. (2021). Electronic Journal Collection Health, 13(5), e6983. https://doi.org/10.25248/reas.e6983.2021

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: Analyze the heart transplant procedure in the treatment of chagasic myocardiopathy taking into consideration the diagnosis, indication, procedure, complications and particularities that approach this subject, to better understand this technique. Bibliographic review: Chagas Disease is caused by the flagella protozoan Trypanosoma Cruzi, representing the third most prevalent parasitic infection in the world. The reports of CD reactivation are common findings in immunosuppressive conditions such as AIDS, autoimmune diseases, cancer (and the chemotherapy used to treat it) and, of course, pharmacological immunosuppression to prevent transplant rejection. Among the peri-operative complications destructive life habits, such as smoking and alcoholism, which promote the aggravation of cardiovascular problems, are highlighted. Post-operative complications include neoplasms such as lymphoma Kaposi’s sarcoma and the possibility of T. Cruzi reactivation due to induced immunosuppression which begins after surgery in order to avoid acute graft rejection. Final considerations: Finally, the importance of a holistic knowledge regarding the particularities of the chagasic disease, such as the risk of re-infection in immunosuppressed patients, is highlighted in order to reduce the chances of postoperative complications.

PDF (Portuguese (Brazil))